NO20091607L - Rasjonalt designet media for cellekultur - Google Patents

Rasjonalt designet media for cellekultur

Info

Publication number
NO20091607L
NO20091607L NO20091607A NO20091607A NO20091607L NO 20091607 L NO20091607 L NO 20091607L NO 20091607 A NO20091607 A NO 20091607A NO 20091607 A NO20091607 A NO 20091607A NO 20091607 L NO20091607 L NO 20091607L
Authority
NO
Norway
Prior art keywords
concentration
amino acid
cell
media
cell culture
Prior art date
Application number
NO20091607A
Other languages
English (en)
Norwegian (no)
Inventor
Denis Drapeau
Wenge Wang
Yen-Tung Luan
Ryan Nolan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39430451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20091607(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20091607L publication Critical patent/NO20091607L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20091607A 2006-11-08 2009-04-22 Rasjonalt designet media for cellekultur NO20091607L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85828906P 2006-11-08 2006-11-08
PCT/US2007/083947 WO2008063892A2 (en) 2006-11-08 2007-11-07 Rationally designed media for cell culture

Publications (1)

Publication Number Publication Date
NO20091607L true NO20091607L (no) 2009-05-28

Family

ID=39430451

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091607A NO20091607L (no) 2006-11-08 2009-04-22 Rasjonalt designet media for cellekultur

Country Status (26)

Country Link
US (2) US8232075B2 (da)
EP (2) EP2921552A1 (da)
JP (2) JP5564259B2 (da)
KR (1) KR101523782B1 (da)
CN (2) CN104152395B (da)
AR (1) AR063623A1 (da)
AU (1) AU2007323978B2 (da)
BR (1) BRPI0718713B1 (da)
CA (1) CA2668771C (da)
CL (1) CL2007003221A1 (da)
CR (1) CR10781A (da)
DK (1) DK2078071T3 (da)
EC (1) ECSP099313A (da)
ES (1) ES2538986T3 (da)
HK (1) HK1132300A1 (da)
IL (1) IL198486A (da)
MX (1) MX2009004974A (da)
NO (1) NO20091607L (da)
PE (1) PE20081655A1 (da)
PL (1) PL2078071T3 (da)
PT (1) PT2078071E (da)
RU (1) RU2520810C2 (da)
SI (1) SI2078071T1 (da)
TW (1) TW200827445A (da)
WO (1) WO2008063892A2 (da)
ZA (1) ZA200903170B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101523782B1 (ko) 2006-11-08 2015-05-28 와이어쓰 엘엘씨 세포 배양을 위한 합리적으로 설계된 배지
KR101574355B1 (ko) 2007-04-26 2015-12-11 추가이 세이야쿠 가부시키가이샤 고농도 아미노산 함유 배지를 사용한 세포의 배양 방법
EP2188371B1 (en) 2007-08-09 2017-12-20 Wyeth LLC Use of perfusion to enhance production of fed-batch cell culture in bioreactors
US8241904B2 (en) * 2008-08-06 2012-08-14 Praxair Technology, Inc. System and method for controlling a mammalian cell culture process
US8178318B2 (en) * 2008-08-06 2012-05-15 Praxair Technology, Inc. Method for controlling pH, osmolality and dissolved carbon dioxide levels in a mammalian cell culture process to enhance cell viability and biologic product yield
WO2011031397A1 (en) 2009-08-06 2011-03-17 Genentech, Inc. Method to improve virus removal in protein purification
US20110262965A1 (en) * 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
US9428727B2 (en) * 2010-04-26 2016-08-30 Novartis Ag Cell culture medium
MX2012012528A (es) 2010-04-26 2012-11-23 Novartis Ag Proceso de cultivo celular mejorado.
ES2434737T3 (es) * 2010-10-27 2013-12-17 Lonza Biologics Plc. Procedimiento rápido de selección de células (líneas celulares) dirigida
PT105484A (pt) 2011-01-14 2012-07-16 Univ Nova De Lisboa Um método de ambientómica funcional para engenharia de meio de cultura celular
CN103827292B (zh) 2011-07-01 2018-01-26 安姆根有限公司 哺乳动物细胞培养
WO2013009648A2 (en) 2011-07-08 2013-01-17 Momenta Pharmaceuticals, Inc. Cell culture process
SI2969099T2 (sl) * 2013-03-14 2022-04-29 Amgen Inc. Odstranjevanje izluženega afinitetnega purifikacijskega liganda
AR095196A1 (es) * 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
TW202340452A (zh) 2015-08-04 2023-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
WO2017085602A1 (en) * 2015-11-17 2017-05-26 Pfizer Inc. Media and fermentation methods for producing polysaccharides in bacterial cell culture
JP7253923B2 (ja) * 2016-04-05 2023-04-07 ファイザー・インク 細胞培養プロセス
CN106096077B (zh) * 2016-05-26 2019-05-21 新乡医学院 培养基优化方法
JP6314201B1 (ja) * 2016-11-21 2018-04-18 テラファーマ株式会社 樹状細胞洗浄液及びこれを用いた樹状細胞の洗浄方法、並びに樹状細胞含有組成物の調製方法
KR102322530B1 (ko) * 2017-02-08 2021-11-05 화이자 인코포레이티드 캡핑된 및 비-캡핑된 항체 시스테인의 대규모 제조 공정 및 치료 단백질 접합에서의 그의 용도
GB201708655D0 (en) * 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
WO2019079165A1 (en) * 2017-10-16 2019-04-25 Regeneron Pharmaceuticals, Inc. RAMAN IN SITU SPECTROSCOPY SYSTEMS AND METHODS FOR CONTROLLING PROCESSING VARIABLES IN CELL CULTURES
US20210171901A1 (en) * 2017-11-16 2021-06-10 Life Technologies Corporation Streamlined methods for making liquid media
JP6385607B2 (ja) * 2018-02-13 2018-09-05 テラファーマ株式会社 樹状細胞ワクチン
CN108823173A (zh) * 2018-07-24 2018-11-16 郑州伊美诺生物技术有限公司 用于杂交瘤细胞培养的补料培养基及其制备方法
CN109576203B (zh) * 2018-12-20 2021-03-23 吉林省浦生泰生物技术有限责任公司 一种基于中药添加剂的复合益生菌培养基及其制备方法
CN111748527B (zh) * 2020-05-15 2021-01-29 上海多宁生物科技有限公司 化学成分限定高效补料培养基及其制备方法和应用
CN113450882B (zh) * 2020-09-27 2022-03-01 深圳太力生物技术有限责任公司 一种基于人工智能的基础培养基配方开发方法及系统
JP2022060169A (ja) 2020-10-02 2022-04-14 ファイザー・インク Rsv fタンパク質生産のための細胞培養工程
JP2022184798A (ja) 2021-06-01 2022-12-13 ファイザー・インク sFGFR3ポリペプチドを生産するための細胞培養方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282326A (en) 1978-10-12 1981-08-04 Jeanne Moldenhauer Cell culture medium supplement
US4510245A (en) 1982-11-18 1985-04-09 Chiron Corporation Adenovirus promoter system
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4968615A (en) 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
GB8927546D0 (en) 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB2251249B (en) 1990-12-28 1995-06-21 Mogam Biotech Res Inst High-density medium for animal cell culture
USH1532H (en) 1993-11-03 1996-05-07 Genetics Institute, Inc. Adaption of mammalian cell lines to high cell densities
US5399677A (en) 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
RU2141531C1 (ru) * 1999-05-26 1999-11-20 Российское акционерное общество открытого типа "Биопрепарат" Способ получения рекомбинантного инсулина человека
JP4668498B2 (ja) 1999-10-19 2011-04-13 協和発酵キリン株式会社 ポリペプチドの製造方法
ES2344789T5 (es) 2003-05-15 2017-06-14 Wyeth Llc Alimentación restringida de glucosa para el cultivo de células animales
CA2542121A1 (en) 2003-10-09 2005-04-21 Kyowa Hakko Kogyo Co., Ltd. Genomically modified cell neutralized to serum-free system
TWI384069B (zh) * 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
US7300773B2 (en) * 2004-08-27 2007-11-27 Wyeth Research Ireland Limited Production of TNFR-Ig
TWI374935B (en) * 2004-08-27 2012-10-21 Pfizer Ireland Pharmaceuticals Production of α-abeta
ATE541919T1 (de) 2005-02-11 2012-02-15 Novo Nordisk Healthcare Ag Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält
DK1869065T3 (da) 2005-03-11 2020-06-08 Wyeth Llc Fremgangsmåde til kromatografi med svag opdeling
KR101523782B1 (ko) 2006-11-08 2015-05-28 와이어쓰 엘엘씨 세포 배양을 위한 합리적으로 설계된 배지

Also Published As

Publication number Publication date
KR20090079254A (ko) 2009-07-21
BRPI0718713A2 (pt) 2013-11-26
RU2520810C2 (ru) 2014-06-27
AR063623A1 (es) 2009-02-04
CR10781A (es) 2009-06-09
KR101523782B1 (ko) 2015-05-28
ZA200903170B (en) 2010-03-31
CA2668771C (en) 2016-03-15
ES2538986T3 (es) 2015-06-25
JP2010508853A (ja) 2010-03-25
MX2009004974A (es) 2009-05-20
ECSP099313A (es) 2009-06-30
WO2008063892A3 (en) 2008-08-28
EP2078071A2 (en) 2009-07-15
PL2078071T3 (pl) 2015-07-31
BRPI0718713B1 (pt) 2019-12-24
WO2008063892A2 (en) 2008-05-29
AU2007323978A1 (en) 2008-05-29
PE20081655A1 (es) 2008-12-03
JP5564259B2 (ja) 2014-07-30
CL2007003221A1 (es) 2008-05-16
US8232075B2 (en) 2012-07-31
EP2078071B1 (en) 2015-03-18
CA2668771A1 (en) 2008-05-29
JP2014128276A (ja) 2014-07-10
IL198486A0 (en) 2011-08-01
EP2921552A1 (en) 2015-09-23
IL198486A (en) 2015-06-30
TW200827445A (en) 2008-07-01
CN104152395B (zh) 2020-03-10
RU2009114855A (ru) 2010-12-20
US20130084593A1 (en) 2013-04-04
AU2007323978B2 (en) 2012-08-16
CN104152395A (zh) 2014-11-19
PT2078071E (pt) 2015-07-16
CN101535469A (zh) 2009-09-16
US20080108553A1 (en) 2008-05-08
DK2078071T3 (da) 2015-04-20
SI2078071T1 (sl) 2015-05-29
HK1132300A1 (en) 2010-02-19

Similar Documents

Publication Publication Date Title
NO20091607L (no) Rasjonalt designet media for cellekultur
NO20091992L (no) Nye vitamin D2 gjaerprepareringer, en fremgangsmate for fremstilling og anvendelse derav
NZ717429A (en) Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
MY185872A (en) Cell culture improvements
EP1921090A4 (en) GENETICALLY MODIFIED ANTIBODY COMPOSITION
WO2008013943A3 (en) High-cell density fed-batch fermentation process for producing recombinant protein
MY161785A (en) Compositions and methods to sequester flue gas mercury in concrete
BRPI0613543B8 (pt) Método para produção de 1,3-propanodiol usando glicerol bruto, um subproduto da produção de biodiesel
IN2012DN01087A (da)
WO2009137624A3 (en) Hemangio colony forming cells and non-engrafting hemangio cells
BRPI0914440A8 (pt) Método para produção biogênica de etanol e cianobactéria geneticamente modificada
EA200900331A1 (ru) Комбинированная установка для получения биогаза и компоста и способ переключения ферментера в такой установке между производством биогаза и компоста
EA201400192A1 (ru) Клетка, ферментирующая пентозы
UA111953C2 (uk) Високоміцний цемент на фосфатній основі, який має низьку лужність
CN102618349A (zh) 一种甲烷化学链燃烧的氧载体及其制备方法
FR2944716B1 (fr) Catalyseur et procede d'oxydation electrochimique du methane
WO2012011962A3 (en) Production of arabitol
DE602007007631D1 (de) Verfahren zur umwandlung von metallnitraten
NO20075911L (no) Genetisk modifisert mikroorganisme og fremgangsmate for fremstilling av makrolidforbindelser ved anvendelse av mikroorganismen
WO2008071632A3 (de) Verfahren zur isolierung von n2o
EP1715339A3 (de) Verfahren zur Ermittlung der Anteile biogener und fossiler Energieträger sowie biogener und fossiler Kohlendioxidemissionen beim Betrieb von Verbrennungsanlagen
NZ596626A (en) Synthesis of sialic acid in plants
WO2010034935A3 (fr) Composition catalytique pour le traitement des gaz de combustion du charbon, son procede de preparation, systeme catalytique la comprenant et utilisation
US20220403321A1 (en) Algae cultivation medium and method of increasing carbon shuttling in an algae cultivation medium
WO2011015920A3 (en) A highly efficient process of purification and production of recombinant trastuzumab

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application